Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours
1998

Study of Dihydropyrimidine Dehydrogenase in Colorectal Cancer

Sample size: 63 publication Evidence: moderate

Author Information

Author(s): HL McLeod, J Sludden, GI Murray, RA Keenan, Al Davidson, K Park, M Koruth, J Cassidy

Primary Institution: University of Aberdeen

Hypothesis

How does dihydropyrimidine dehydrogenase (DPD) activity vary in colorectal tumors compared to normal tissue?

Conclusion

DPD activity is highly variable in colorectal tumors and is generally lower than in adjacent normal tissue.

Supporting Evidence

  • DPD activity was highly variable in all tissues studied.
  • The median tumor-normal activity ratio was 0.76.
  • PMNC DPD activity was correlated with tumor activity.
  • DPD activity was significantly higher in normal tissue than in tumor.
  • Only three specimens had a tumor-normal ratio greater than 2.

Takeaway

This study looked at how an enzyme that breaks down a cancer drug works in tumors and normal tissue, finding that tumors often break it down less.

Methodology

DPD activity was measured in tumor, adjacent normal tissue, and PMNCs from 63 patients undergoing surgery for colorectal cancer.

Limitations

The study did not evaluate the influence of tissue DPD activity on response to 5-FU therapy due to uniform post-operative therapy.

Participant Demographics

32 male and 31 female patients with a median age of 70 years, ranging from 32 to 87 years.

Statistical Information

P-Value

0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication